SS-31 (Elamipretide): What the Research Says About the Mitochondrial-Targeted Peptide
SS-31, also known as elamipretide, is a small peptide that has become a central research tool in the study of mitochondrial biology. Unlike most research peptides, which act on receptors at the cell surface, SS-31 is notable for being studied as a compound that concentrates inside the mitochondria themselves. This article gives an in-depth, research-only overview of what SS-31 is and how the literature describes it.
What is SS-31?
SS-31 belongs to a family of compounds known as Szeto-Schiller (SS) peptides, named after the researchers who first characterized them. Structurally it is a small aromatic-cationic tetrapeptide - a four-amino-acid sequence carrying a positive charge and aromatic groups. This particular combination of properties is what allows it to be studied as a mitochondria-targeting molecule.
Because it is a compact, well-defined peptide, researchers can work with it as a single reproducible molecule, which is part of why it has been used so widely in mechanistic mitochondrial studies.
Why mitochondria are a research focus
Mitochondria are the compartments where cells generate most of their usable energy, and their function tends to decline in many aging and disease models. This makes them a major target of interest across metabolic, cardiac, renal, and neurological research. A compound that can be studied specifically at the mitochondrial level is therefore a valuable tool for asking questions that are hard to address with surface-acting molecules.
How SS-31 is studied to work
In research models, SS-31 is described as associating with cardiolipin, a lipid found on the inner mitochondrial membrane that is important for the organization of the electron transport chain. By interacting with cardiolipin, SS-31 is studied for its apparent role in supporting efficient electron transport and reducing the production of reactive oxygen species (ROS) in these models. The recurring research theme is preservation of mitochondrial membrane structure and function under stress.
It is worth emphasizing that these are observations from laboratory and preclinical study systems, described as mechanisms under investigation rather than established outcomes.
Research themes and contexts
SS-31 appears frequently in preclinical literature examining mitochondrial dysfunction, where researchers use it to probe how much a given process depends on mitochondrial integrity. It has been studied in a range of tissue models that are energetically demanding, since those tissues are where mitochondrial effects tend to be most measurable.
How SS-31 compares to related research compounds
SS-31 is often discussed alongside other compounds studied in mitochondrial and cellular-energy research. MOTS-c is a mitochondrial-derived signalling peptide studied for metabolic questions, and NAD+ is a coenzyme central to cellular energy metabolism. Comparing a membrane-targeting peptide (SS-31), a mitochondrial-derived signalling peptide (MOTS-c), and a metabolic coenzyme (NAD+) is a useful way to see how different research tools approach the same organelle from different angles. The longevity-focused bioregulator Epithalon is sometimes discussed in the same broad research conversation.
Handling and storage
SS-31 is supplied as a lyophilized (freeze-dried) powder for stability and is reconstituted for laboratory work with bacteriostatic water. Follow proper sterile technique, keep reconstituted material cold, and use the reconstitution calculator to work out concentrations.
Quality and verification
Because SS-31 is a short, precisely defined peptide, analytical purity is directly meaningful for reproducible research. Understanding how purity is verified by HPLC and mass spectrometry helps you interpret a Certificate of Analysis before relying on any batch.
Research use only. This article is educational and is not medical, legal, or financial advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.